|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Germline Telomere Biology Defects in Pediatric and Young Adult Acute Myeloid Leuk
|
1K23CA158148-01A1
|
$169,983
|
Gramatges, Maria
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cancer and Leukemia Group B
|
3U10CA031946-31S1
|
$114,228
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-27S1
|
$405,901
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA031946-31
|
$7,759,618
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-28
|
$2,286,202
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Molecular pathogenesis of MLL-AF4 leukemias
|
5R01CA140575-03
|
$350,219
|
ARMSTRONG, SCOTT
|
CHILDREN'S HOSPITAL BOSTON
|
|
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALL
|
7K08CA133103-05
|
$140,940
|
Gutierrez, Alejandro
|
CHILDREN'S HOSPITAL BOSTON
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
5R01CA113969-08
|
$325,549
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL BOSTON
|
|
Center for Environment-Mediated Drug Resistance in Pediatric Cancer
|
5U54CA163117-02
|
$573,087
|
DeClerck, Yves
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Investigating the Role of Adipocytes on Leukemia Relapse
|
5R01CA139060-04
|
$322,443
|
Mittelman, Steven
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Infectious origins of childhood leukemia
|
5R01CA157644-02
|
$332,000
|
Muschen, Markus
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Amplifying Radiation Potency Against Leukemic Stem Cells
|
1R21CA164098-01
|
$211,410
|
UCKUN, FATIH
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALL
|
5R01CA154471-02
|
$332,000
|
UCKUN, FATIH
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles
|
5U01CA151837-03
|
$456,297
|
UCKUN, FATIH
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Promoting Treatment Adherence in Adolescent Leukemia
|
5R01CA119162-06
|
$602,850
|
Drotar, Dennis
|
CHILDREN'S HOSPITAL MEDICAL CENTER CINCI
|
|
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy
|
5R01CA157537-02
|
$317,475
|
PANG, QISHEN
|
CHILDREN'S HOSPITAL MEDICAL CENTER CINCI
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-10S3
|
$176,626
|
ADAMSON, PETER
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Children's Oncology Group Chair's Grant
|
7U10CA098543-10
|
$26,733,729
|
ADAMSON, PETER
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Toxicity Monitoring on Phase III Trials with Administrative Data
|
1R01CA165277-01A1
|
$495,102
|
Aplenc, Richard
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Genetic Predictors of AML Treatment Response
|
5R01CA133881-03
|
$560,885
|
Aplenc, Richard
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
MLL in Hematopoiesis and Leukemia in the Zebrafish Model
|
5R01CA153348-03
|
$402,071
|
Felix, Carolyn
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Delaware/Christiana Care Community Clinical Oncology Program
|
2U10CA045418-26
|
$1,423,934
|
GRUBBS, STEPHEN
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Targeting non-classical oncogenes as therapy for T-ALL
|
1R01CA169162-01
|
$332,000
|
Diacovo, Thomas
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-39S1
|
$140,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-39S2
|
$75,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-39
|
$3,816,425
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of AKT signaling in NOTCH1 induced leukemias
|
5R01CA129382-05
|
$324,613
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of PHF6 in T-cell acute lymphoblastic leukemia
|
5R01CA155743-02
|
$332,000
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Targeting to Epigenetic Modications in ALL
|
1R01CA176745-01
|
$402,250
|
ARMSTRONG, SCOTT
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
2P30CA006516-47
|
$11,164,583
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S1
|
$56,572
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S2
|
$75,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S3
|
$50,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer and Leukemia Group B
|
5U10CA032291-31
|
$495,751
|
Burstein, Harold
|
DANA-FARBER CANCER INSTITUTE
|
|
Development of Novel Therapeutic Strategies in Human Leukemias
|
5P01CA066996-15
|
$2,324,734
|
GRIFFIN, JAMES
|
DANA-FARBER CANCER INSTITUTE
|
|
Discovery of New Targets and Pathways for T-ALL Therapy
|
1R01CA176746-01
|
$378,989
|
LOOK, A
|
DANA-FARBER CANCER INSTITUTE
|
|
Molecular Pathways to Thynmic Lymphoma and Leukemia
|
5P01CA109901-08
|
$2,022,365
|
LOOK, A
|
DANA-FARBER CANCER INSTITUTE
|
|
Pathway Dependence on Tyrosine Kinase TYK2 in T-cell Acute Lymphoblastic Leukemia
|
5K99CA157951-02
|
$137,700
|
Sanda, Takaomi
|
DANA-FARBER CANCER INSTITUTE
|
|
Validating Syk as a Target for AML Therapy
|
5R01CA140292-04
|
$352,231
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer and Leukemia Group B
|
5U10CA047577-25
|
$99,190
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
FitFab 4 Survivors
|
5R21CA155965-02
|
$178,873
|
Fuemmeler, Bernard
|
DUKE UNIVERSITY
|
|
Phenotype-Genotype Associations with Symptoms During Childhood Leukemia Treatment
|
1R01CA169398-01
|
$624,427
|
HOCKENBERRY, MARILYN
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-38S1
|
$75,000
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
5P30CA014236-38
|
$5,723,821
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Feasibility of a Couple-based Intervention for Parents of Children with Cancer
|
1R21CA164817-01A1
|
$170,738
|
PORTER, LAURA
|
DUKE UNIVERSITY
|
|
MDM2 regulates XIAP gene expression in cancer treatment
|
5R01CA123490-05
|
$249,581
|
ZHOU, MUXIANG
|
EMORY UNIVERSITY
|
|
EORTC HEADQUARTERS
|
5U10CA011488-42
|
$235,448
|
Lacombe, Denis
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
North Shore CCOP
|
5U10CA035279-29
|
$611,448
|
VINCIGUERRA, VINCENT
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
Florida Hospital Cancer Institute Community Clinical Oncology Program
|
1U10CA167730-01
|
$700,000
|
ZEHNGEBOT, LEE
|
FLORIDA HOSPITAL
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|